Z-1282-2024 Class II

Recalled by Fresenius Kabi USA, LLC — North Andover, MA

FDA device recall Z-1282-2024 was initiated by Fresenius Kabi USA, LLC on Sep 16, 2022 and is designated Class II. Reason for recall: Retroactively reported correction from 2022: A software defect may cause an incorrect (Fail-Stop) Alarm when an administration set is loaded with an upstream occlusion present, resulting in a… Affected quantity: 3.

Recall Details

Product Type
Devices
Report Date
Mar 20, 2024
Initiation Date
Sep 16, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3

Product Description

LVP software of the Ivenix Infusion System (IIS), LVP-SW-0004

Reason for Recall

Retroactively reported correction from 2022: A software defect may cause an incorrect (Fail-Stop) Alarm when an administration set is loaded with an upstream occlusion present, resulting in a non-recoverable (Fail-Stop) Pump Problem alarm. This may lead to delay of therapy, and patient may experience from no to minimal to serious harm. This issue was resolved in all fielded product in software version 5.2.1, which was installed in September 2022.

Distribution Pattern

US Nationwide distribution in the states of WI and NJ.

Code Information

UDI-DI 00811505030122 Software versions 5.0.1 and earlier.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1282-2024
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.